IS4172A - Joðuð meðseglandi chelates, aðferð til framleiðslu þeirra, notkun efnanna og aðferðir til að auka virkni efnanna - Google Patents

Joðuð meðseglandi chelates, aðferð til framleiðslu þeirra, notkun efnanna og aðferðir til að auka virkni efnanna

Info

Publication number
IS4172A
IS4172A IS4172A IS4172A IS4172A IS 4172 A IS4172 A IS 4172A IS 4172 A IS4172 A IS 4172A IS 4172 A IS4172 A IS 4172A IS 4172 A IS4172 A IS 4172A
Authority
IS
Iceland
Prior art keywords
substances
pct
date
chelates
conjugate
Prior art date
Application number
IS4172A
Other languages
English (en)
Inventor
Uggeri Fulvio
Lucio Anelli Pier
Fedeli Franco
Murru Marcella
De Haen Christoph
Original Assignee
Bracco S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ITMI931155A external-priority patent/IT1270974B/it
Priority claimed from IT001274 external-priority patent/IT1264610B1/it
Application filed by Bracco S.P.A. filed Critical Bracco S.P.A.
Publication of IS4172A publication Critical patent/IS4172A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0438—Organic X-ray contrast-enhancing agent comprising an iodinated group or an iodine atom, e.g. iopamidol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/085—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier conjugated systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
IS4172A 1993-06-02 1994-06-01 Joðuð meðseglandi chelates, aðferð til framleiðslu þeirra, notkun efnanna og aðferðir til að auka virkni efnanna IS4172A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI931155A IT1270974B (it) 1993-06-02 1993-06-02 Chelati paramagnetici iodurati
IT001274 IT1264610B1 (it) 1993-06-15 1993-06-15 Chelati paramagnetici iodurati

Publications (1)

Publication Number Publication Date
IS4172A true IS4172A (is) 1994-12-03

Family

ID=26330998

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4172A IS4172A (is) 1993-06-02 1994-06-01 Joðuð meðseglandi chelates, aðferð til framleiðslu þeirra, notkun efnanna og aðferðir til að auka virkni efnanna

Country Status (9)

Country Link
US (1) US5660814A (is)
EP (1) EP0703790B1 (is)
JP (1) JPH08510458A (is)
AT (1) ATE195432T1 (is)
AU (1) AU6996594A (is)
DE (1) DE69425572T2 (is)
IL (1) IL109852A0 (is)
IS (1) IS4172A (is)
WO (1) WO1994027644A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4302287A1 (de) * 1993-01-25 1994-07-28 Schering Ag Derivatisierte DTPA-Komplexe, diese Verbindungen enthaltende pharmazeutische Mittel, ihre Verwendung und Verfahren zu deren Herstellung
US5672335A (en) * 1994-11-30 1997-09-30 Schering Aktiengesellschaft Use of metal complexes as liver and gallbladder X-ray diagnostic agents
TW319763B (is) * 1995-02-01 1997-11-11 Epix Medical Inc
FR2736051B3 (fr) * 1995-06-29 1997-09-26 Guerbet Sa Complexes metalliques de polyaminoacides, leur procede de preparation et leur utilisation en imagerie diagnostique
US5834456A (en) * 1996-02-23 1998-11-10 The Dow Chemical Company Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
JP2003520192A (ja) * 1998-10-29 2003-07-02 ザ ゼネラル ホスピタル コーポレーション 強化された放射線治療
WO2004031348A2 (en) * 2002-09-24 2004-04-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for convection enhanced delivery of therapeutic agents
ITMI20022411A1 (it) * 2002-11-14 2004-05-15 Bracco Imaging Spa Agenti per la diagnosi e la terapia di tumori che espongono sulla superficie delle cellule proteine alterate.
DE10307759B3 (de) * 2003-02-19 2004-11-18 Schering Ag Trimere makrocyclisch substituierte Benzolderivate, deren Herstellung und Verwendung als Kontrastmittel sowie diese enthaltende pharmazeutische Mittel
US7208140B2 (en) 2003-02-19 2007-04-24 Schering Aktiengesellschaft Trimeric macrocyclic substituted benzene derivatives
DE102004023093B3 (de) * 2004-05-05 2006-03-02 Schering Ag Trimere makrocyclisch substituierte Halogen-Benzolderivate
DE102004026103A1 (de) * 2004-05-25 2005-12-22 Schering Ag Trimere makrocyclisch substituierte Aminoisophthalsäure-Halogen-Benzolderivate
KR100695744B1 (ko) * 2005-05-03 2007-03-19 한국원자력연구소 디티피에이(ｄｔｐａ) 유도체 및 이들을 이용한 금속 착화물, 이들을 포함하는 방사선원 및 조영제
EP1762563A1 (en) * 2005-09-13 2007-03-14 BRACCO IMAGING S.p.A. Process for the preparation of contrast agents
EP2073723A4 (en) * 2006-10-10 2011-03-30 Mayo Foundation REDUCTION OF TOXICITY INDUCED BY A CONTRAST AGENT
NO20073382L (no) * 2007-06-29 2008-12-30 Ge Healthcare As Contrast Agents
DE102007058220A1 (de) 2007-12-03 2009-06-04 Bayer Schering Pharma Aktiengesellschaft Dimere macrocyclisch substituierte Benzolderivate
GB0808086D0 (en) * 2008-05-02 2008-06-11 Iti Scotland Ltd Magnetic proteins for in vivo imaging
KR101638851B1 (ko) * 2014-06-13 2016-07-12 경북대학교 산학협력단 신규한 삼요오드화 화합물, 이의 제조방법 및 이를 포함하는 x-선 조영제
EP3101012A1 (en) 2015-06-04 2016-12-07 Bayer Pharma Aktiengesellschaft New gadolinium chelate compounds for use in magnetic resonance imaging
EP3544964B1 (en) 2016-11-28 2020-06-17 Bayer Pharma Aktiengesellschaft High relaxivity gadolinium chelate compounds for use in magnetic resonance imaging
AU2019382881A1 (en) 2018-11-23 2021-05-20 Bayer Aktiengesellschaft Formulation of contrast media and process of preparation thereof
EP4015509A1 (en) 2020-12-18 2022-06-22 Justesa Imagen S.A.U Organometallic compounds and their use as multimodal contrasting media for imaging diagnosis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1213029B (it) * 1986-01-30 1989-12-07 Bracco Ind Chimica Spa Chelati di ioni metallici paramagnetici.
GB8916781D0 (en) * 1989-07-21 1989-09-06 Nycomed As Compositions
US5324503A (en) * 1992-02-06 1994-06-28 Mallinckrodt Medical, Inc. Iodo-phenylated chelates for x-ray contrast
US5525328A (en) * 1994-06-24 1996-06-11 Nanosystems L.L.C. Nanoparticulate diagnostic diatrizoxy ester X-ray contrast agents for blood pool and lymphatic system imaging

Also Published As

Publication number Publication date
DE69425572D1 (de) 2000-09-21
WO1994027644A1 (en) 1994-12-08
US5660814A (en) 1997-08-26
JPH08510458A (ja) 1996-11-05
EP0703790B1 (en) 2000-08-16
AU6996594A (en) 1994-12-20
ATE195432T1 (de) 2000-09-15
DE69425572T2 (de) 2001-04-26
IL109852A0 (en) 1994-10-07
EP0703790A1 (en) 1996-04-03

Similar Documents

Publication Publication Date Title
IS4172A (is) Joðuð meðseglandi chelates, aðferð til framleiðslu þeirra, notkun efnanna og aðferðir til að auka virkni efnanna
ATE135237T1 (de) Molekularsieb enthaltende pharmazeutische ionen für diagnose
IS4114A (is) Vatnskenndar sprautanlegar efnasamsetningar nytsamlegar við geislagreiningu og sem samanstanda af joðuðum hringtengdum efnasamböndum sem notuð eru sem skuggaefni við röntgenmyndatöku
Jacobo et al. Comparison of flutamide (SCH-13521) and diethylstilbestrol in untreated advanced prostatic cancer
ES8603757A1 (es) Procedimiento para la obtencion de un complejo lantanido de efecto modificador del contraste de una imagen medica por rmn
IL129173A0 (en) Gas-filled microvesicles and a process for preparing an mri contrast agent containing same
IL143730A0 (en) Blood pool agents for nuclear magnetic resonance diagnostics
DE69819478T2 (de) Verfahren zum Nachweis und zur Lokalisierung maligner menschlicher Pankreastumore
RU94045155A (ru) Способы ингибирования болезни альцгеймера
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
GR3004576T3 (is)
ATE99544T1 (de) Liposomale radiologische kontrastmittel.
EA200300507A1 (ru) Радиофармацевтические агенты для диагностики болезни альцгеймера
IL109115A0 (en) Methods for measurement of nmr-detectable xenobiotic compounds
GEP20053423B (en) Method of Inhibiting Amyloid Protein Aggregation and Method for Imaging of Amyloid Deposits
ES2117670T3 (es) Derivado de hidroxamato e hidrazida de poliaminas y su uso medico como agentes quelantes.
WO2001051095A3 (de) Paramagnetische dota-derivate, diese enthaltende pharmazeutische mittel, verfahren zu ihrer herstellung und ihre verwendung für das nekrose- und infarkt-mr-imaging
IL108433A0 (en) Dtpa metal complex derivatives, pharmaceutical compositions containing the same, and methods for the preparation thereof
GR3020861T3 (en) Mri image enhancement of bone and related tissue using complexes of paramagnetic cations and polyphosphonate ligands